Implication of Surfactant Apoprotein in Otitis Media with Effusion

Abstract

A two-site simultaneous immunoassay using monoclonal antibodies against human surfactant apoprotein (SAP) was used to measure SAP in middle ear effusions (MEEs). In 130 MEE samples from children with otitis media with effusion, SAP was detected in 54 samples (SAP-positive cases, 41.5%). In the remainder, the SAP concentration was below the sensitivity of the immunoassay (SAP-negative cases, 58.5%). A significant difference in periods of observation was found between the SAP-positive cases (17.3 ± 16.8 months) and the SAP-negative cases (26.2 ± 22.5 months) (p < .01). The percentage of positive cases was highest in the serous MEE group (81.2%) and decreased in the purulent MEE group (57%), the mucoid MEE group (30%), and the hyperviscous MEE group (13.6%), in that order. In the purulent MEE group and the mucoid MEE group, the period of observation was significantly shorter in the SAP-positive cases (18.3 ± 20.4 months and 20.2 ± 19.4 months) than in the SAP-negative cases (35.9 ± 24.5 months and 25.4 ± 18.7 months) (p < .05). These results suggest that SAP is present in the middle ear cleft and may be a good prognostic predictor of otitis media with effusion in children.

Keywords

immunoassay middle ear effusion monoclonal antibodies otitis media with effusion surfactant apoprotein

Get full access to this article

View all access options for this article.

References

Bauer

. The use of urea in exudative otitis media. Otolaryngol Clin North Am 1970; 3: 67–78.

Birken

Brookler

. Surface tension lowering substance of the canine eustachian tube. Ann Otol Rhinol Laryngol 1972; 81: 268–71.

Hagan

. Surface tension lowering substance in eustachian tube function. Laryngoscope 1977; 87: 1033–45.

Hills

. Analysis of eustachian surfactant and its function as a release agent. Arch Otolaryngol 1984; 110: 3–9.

Grace

Kwok

Hawke

. Surfactant in middle ear effusions. Otolaryngol Head Neck Surg 1987; 96: 336–40.

Kuroki

Fukada

Takahashi

Akino

. Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay. Biochim Biophys Acta 1985; 836: 201–9.

Kuroki

Takahashi

Fukada

. Two-site “simultaneous” immunoassay with monoclonal antibodies for the determination of surfactant apoproteins in human amniotic fluid. Pediatr Res 1985; 19: 1017–20.

Shimizu

Hosoda

Mizumoto

. Improved immunoassay for the determination of surfactant apoprotein (SAP) in human amniotic fluid. Tohoku J Exp Med 1989; 157: 269–78.

Suzuki

Kogashi

Fujita

Kina

Nishikawa

. A monoclonal antibody to the 15,000 dalton protein associated with porcine pulmonary surfactant. Exp Lung Res 1986; 11: 61–73.

10.

King

Martin

Baseman

Morrison-Plummer

. Analysis of proteins in rabbit pulmonary surfactant using monoclonal antibodies. Am J Physiol 1986; 250: C460–C467.

11.

King

Ruch

Creasy

. Appearance of apoproteins of pulmonary surfactant in human amniotic fluid. J Appl Physiol 1975; 39: 735–41.

12.

Senturia

. Classification of middle ear effusions. Ann Otol Rhinol Laryngol 1970; 79: 358–70.

13.

White

. Effect of exogenous surfactant on eustachian tube function in the rat. Am J Otolaryngol 1989; 10: 301–4.

14.

Curstedt

Jornvall

Robertsson

Bergman

Berggren

. Two hydrophobic low-molecular mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. Eur J Biochem 1987; 168: 255–62.

15.

Maves

Patil

Lim

. Surface-active substances of the guinea pig tubotympanum: a chemical and physical analysis. Otolaryngol Head Neck Surg 1981; 89: 307–16.